Loveland, Ohio-based Cold Jet LLC is investing $4.9 million into a new campus to consolidate its headquarters, manufacturing and assembly facilities and add 67 more jobs to handle growth for its dry ice blasting and production technology.
Founded in 1988, Cold Jet's two lines of business are centered on use of dry ice as a blasting medium for manufacturers and as a cold-transport medium for food and more recently, medical products.
In plastics, Cold Jet uses dry ice as a non-abrasive method to clean molds.
The expansion project in nearby Miami Township will retain 120 jobs and, over the next three years, create 67 more jobs for machinists, assemblers, engineers, technicians, welders, marketing managers and sales representatives.
Creating a world-class facility will attract employees and customers, allow product demonstrations at the headquarters site, and make room to expand production capacity and staff, according to company officials.
"While Cold Jet has grown to 300 employees with 13 centers of excellence in 10 countries, our roots are in Cincinnati," Christian Rogiers, Cold Jet's senior vice president of global marketing, said in a news release. "Our new global headquarters will serve as a true reflection of Cold Jet's innovative, green technologies as well as our people's values."
Cold Jet also has manufacturing plants in Bramming, Denmark, and Oborniki, Poland, and distribution, sales and service offices worldwide.
In Ohio, the expansion project will generate $5 million in new annual payroll in Clermont County while retaining $12.2 million in existing payroll, according to a news release from Ohio Gov. Mike DeWine.
The project received a 1.567 percent, eight-year Job Creation Tax Credit from the Ohio Tax Credit Authority, the release also says.
In June, Cold Jet officials had announced an investment partnership with two financial firms aimed at helping the company grow in the life sciences market and meet increased demand from manufacturers meeting sustainability goals through operational improvements.
After the pandemic was declared in March 2020, pharmaceutical companies started turning to Cold Jet for delivering vaccines, which require cold-chain management from the point of manufacture to the point of use.
The company's foray into life sciences also has generated business from research groups and for cell therapy applications.
In the manufacturing sector, Cold Jet provides systems for cleaning, surface preparation and parts finishing. The use of dry ice as a blasting material puts recycled carbon dioxide to work instead of water, which helps companies meet sustainability goals.
Cold Jet's investment partners are Marina del Rey, Calif.-based Seidler Equity Partners and Columbus, Ohio-based Stonehenge Partners.